C

Corbus Pharmaceuticals Holdings
D

CRBP

11.350
USD
-0.62
(-5.18%)
مغلق
حجم التداول
8,269
الربح لكل سهم
-5
العائد الربحي
-
P/E
-2
حجم السوق
138,237,121
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ACAD
    -0.085
    (-0.48%)
    17.805 USD
    A
    AKTX
    0.10000
    (8.33%)
    1.30000 USD
    C
    CARA
    -0.07000
    (-1.49%)
    4.63000 USD
    C
    CRSP
    2.740
    (6.61%)
    44.200 USD
    M
    MRNS
    0.00370
    (0.68%)
    0.54470 USD
    T
    TLRY
    -0.04000
    (-3.40%)
    1.13500 USD
    المزيد
الأخبار
المقالات

العنوان: Corbus Pharmaceuticals Holdings

القطاع: Healthcare
الصناعة: Biotechnology
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.